Fulgent Genetics (FLGT) Change in Accured Expenses (2016 - 2025)
Fulgent Genetics (FLGT) has disclosed Change in Accured Expenses for 11 consecutive years, with $12.3 million as the latest value for Q4 2025.
- Quarterly Change in Accured Expenses rose 1862.58% to $12.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.9 million through Dec 2025, up 324.97% year-over-year, with the annual reading at $8.9 million for FY2025, 324.97% up from the prior year.
- Change in Accured Expenses hit $12.3 million in Q4 2025 for Fulgent Genetics, up from -$1.1 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $20.0 million in Q2 2021 to a low of -$13.2 million in Q3 2022.
- Historically, Change in Accured Expenses has averaged $491700.0 across 5 years, with a median of $225500.0 in 2023.
- Biggest five-year swings in Change in Accured Expenses: soared 4879.35% in 2021 and later crashed 932.2% in 2024.
- Year by year, Change in Accured Expenses stood at -$8.2 million in 2021, then surged by 124.35% to $2.0 million in 2022, then skyrocketed by 423.32% to $10.4 million in 2023, then plummeted by 93.97% to $628000.0 in 2024, then skyrocketed by 1862.58% to $12.3 million in 2025.
- Business Quant data shows Change in Accured Expenses for FLGT at $12.3 million in Q4 2025, -$1.1 million in Q3 2025, and $5.2 million in Q2 2025.